- Home
- AKRO vs ASB Comparison
AKRO vs ASB Comparison
Compare AKRO & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- ASB
- Stock Information
- Founded
- AKRO 2017
- ASB 1861
- Country
- AKRO United States
- ASB United States
- Employees
- AKRO N/A
- ASB N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- ASB Major Banks
- Sector
- AKRO Health Care
- ASB Finance
- Exchange
- AKRO Nasdaq
- ASB Nasdaq
- Market Cap
- AKRO 3.7B
- ASB 4.4B
- IPO Year
- AKRO 2019
- ASB N/A
- Fundamental
- Price
- AKRO $46.50
- ASB N/A
- Analyst Decision
- AKRO Strong Buy
- ASB Hold
- Analyst Count
- AKRO 8
- ASB 11
- Target Price
- AKRO $80.38
- ASB $27.82
- AVG Volume (30 Days)
- AKRO 1.2M
- ASB 1.4M
- Earning Date
- AKRO 11-07-2025
- ASB 10-23-2025
- Dividend Yield
- AKRO N/A
- ASB 3.46%
- EPS Growth
- AKRO N/A
- ASB N/A
- EPS
- AKRO N/A
- ASB 0.78
- Revenue
- AKRO N/A
- ASB $1,035,964,000.00
- Revenue This Year
- AKRO N/A
- ASB $56.79
- Revenue Next Year
- AKRO N/A
- ASB $5.82
- P/E Ratio
- AKRO N/A
- ASB $33.89
- Revenue Growth
- AKRO N/A
- ASB 3.82
- 52 Week Low
- AKRO $21.34
- ASB $18.32
- 52 Week High
- AKRO $58.40
- ASB $28.18
- Technical
- Relative Strength Index (RSI)
- AKRO 47.87
- ASB 58.66
- Support Level
- AKRO $45.20
- ASB $25.18
- Resistance Level
- AKRO $47.40
- ASB $26.88
- Average True Range (ATR)
- AKRO 1.46
- ASB 0.49
- MACD
- AKRO 0.06
- ASB 0.03
- Stochastic Oscillator
- AKRO 34.90
- ASB 80.35
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About ASB Associated Banc-Corp
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.